TABLE 2.
Proportion of population consuming dietary supplements across T2D-M1 and T2D-M2 diabetes definitions1
| Supplement use | T2D-M1 diabetes (n = 2878) | T2D-M2 diabetes (n = 3850) |
| Any supplement taken | ||
| No | 44.2 (41.4, 47.0) | 41.9 (39.4, 44.5) |
| Yes | 55.8 (53.0, 58.6) | 58.1 (55.5, 60.7) |
| Supplement with chromium taken | ||
| No | 74.4 (71.5, 76.7) | 72.4 (70.2, 74.6) |
| Yes | 25.6 (23.3, 28.5) | 27.6 (25.4, 29.8) |
| Supplement with chromium taken, if at least 1 supplement taken | ||
| No | 53.9 (49.4, 58.3) | 52.8 (49.0, 56.5) |
| Yes | 46.1 (41.7, 50.6) | 47.2 (43.5, 51.0) |
| Supplement taken with chromium in name | ||
| No | 0.6 (0.5, 0.7) | 0.5 (0.4, 0.7) |
| Yes | 1.9 (1.1, 2.8) | 2.0 (1.3, 2.7) |
1
Values are % (95% CI). HbA1c, glycated hemoglobin; T2D-M1, type 2 diabetes defined on the basis of HbA1c values only; T2D-M2, type 2 diabetes defined by both HbA1c values and doctor diagnosis.